University Clinical Research Center & Faculty of Medicine and Odontostomatology University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
Collaborative Clinical Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Disease National Institutes of Health, 5601 Fishers Lane, Rockville, MD, 20852, USA.
Health Res Policy Syst. 2020 Sep 17;18(1):105. doi: 10.1186/s12961-020-00623-8.
Mali, like the rest of the world, has seen a rapid spread of COVID-19 since the first report of imported cases. Despite being a low-income country, Mali has leveraged scientific research resources via coordinated approaches to enable public health emergency planning and response to the COVID-19 pandemic. Mali's approach includes the harmonization of research activities; leveraging of research laboratory capacity of the University Clinical Research Center, Mali International Center for Excellence and three other in-country laboratories for community COVID-19 testing; strengthening relationships amongst local and international stakeholders; and collaboration with the Ministry of Health to integrate scientific evidence into public policy and emergency management of COVID-19 through a platform of consultation and open communication. The country has implemented national coordination of its COVID-19 response by establishing a COVID-19 Scientific Advisory Committee and a COVID-19 Technical Coordination Committee, both within the Ministry of Health and working collaboratively with other stakeholders. Members of Mali's COVID-19 Scientific Advisory Committee also serve as leaders of its principal academic and government clinical and public health research entities. This centralised approach has enabled the prioritisation of COVID-19 control activities, informed allocation of resources, evidence-based public health practices and timely decision-making in the pandemic setting. Though challenges remain, lessons learned from Mali's harnessing of clinical research capacity to guide and support its COVID-19 response can be applied to future global health research challenges and illustrate the power of building public health-responsive research capacity in resource-limited settings through international collaboration.
马里与世界其他地区一样,自首例输入性病例报告以来,COVID-19 迅速蔓延。尽管马里是一个低收入国家,但通过协调一致的方法利用科学研究资源,为 COVID-19 大流行的公共卫生应急规划和应对提供了支持。马里的方法包括:协调研究活动;利用马里临床研究中心、马里国际卓越研究中心和另外三个国内实验室的研究实验室能力,对社区进行 COVID-19 检测;加强地方和国际利益攸关方之间的关系;与卫生部合作,通过协商和公开交流的平台,将科学证据纳入 COVID-19 公共政策和应急管理。该国通过在卫生部内设立 COVID-19 科学咨询委员会和 COVID-19 技术协调委员会,对 COVID-19 应对工作进行了国家协调,并与其他利益攸关方合作。马里 COVID-19 科学咨询委员会的成员还担任其主要学术和政府临床及公共卫生研究实体的领导人。这种集中的方法使 COVID-19 控制活动得到了优先考虑,资源得到了合理分配,公共卫生实践有了证据支持,大流行背景下的决策也更加及时。尽管仍面临挑战,但马里利用临床研究能力为 COVID-19 应对提供指导和支持所吸取的经验教训,可以应用于未来的全球卫生研究挑战,并展示了通过国际合作在资源有限的环境中建立对公共卫生有响应能力的研究能力的力量。